RPG Life Sciences

RPG Life Sciences

2,281.10
+18.40
(0.81%)
Market Cap
3,772.71 Cr
EPS
110.80
PE Ratio
36.13
Dividend Yield
1.06 %
Industry
Healthcare
52 Week High
2,974.95
52 Week Low
1,835.00
PB Ratio
7.05
Debt to Equity
0.00
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,632.90
#1 3,91,787.41
34.36
#1 54,729.00
9.71
#1 10,980
-19.84
46.65
6,189.50
1,64,311.78
70.57
9,712.00
18.67
2,191
26.74
37.51
1,565.00
1,26,406.27
23.42
28,409.50
7.12
5,291
9.88
62.75
3,631.10
1,22,892.92
60.70
11,539.40
6.99
1,911
19.91
57.93
1,255.50
1,04,780.40
#1 18.50
33,741.20
16.73
5,725
1.26
53.20
2,469.50
1,01,923.36
53.98
12,744.20
#1 20.90
2,007
-18.14
44.22
979.25
98,535.46
21.34
23,511.00
18.55
4,615
2.60
57.97
1,971.80
90,051.21
24.20
22,909.50
13.74
3,306
#1 51.64
53.80
32,665.00
69,410.84
48.63
6,684.70
9.64
1,414
11.55
48.48
5,356.00
64,039.01
28.11
13,458.30
3.70
2,216
21.39
68.13

Automatic Screeners on ScanX

Forecast
Actual
Growth Rate
Revenue Growth
13.03 %
Net Income Growth
108.89 %
Cash Flow Change
-17.49 %
ROE
47.67 %
ROCE
40.14 %
EBITDA Margin (Avg.)
12.63 %

Yearly Financial Results

Annual Financials
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
TTM
Revenue
243
280
294
345
331
376
390
443
518
589
666
782
Expenses
228
256
266
306
297
316
319
354
410
454
494
528
EBITDA
15
24
28
39
34
60
71
89
108
135
172
254
Operating Profit %
6 %
8 %
9 %
11 %
10 %
16 %
18 %
20 %
20 %
22 %
24 %
20 %
Depreciation
11
10
11
14
15
16
17
16
16
17
21
21
Interest
3
3
3
4
4
2
1
1
0
0
1
1
Profit Before Tax
1
12
15
20
15
37
54
73
92
118
233
232
Tax
0
0
3
7
4
7
14
22
24
30
50
49
Net Profit
1
12
12
14
11
29
40
52
68
88
183
183
EPS in ₹
0.60
7.03
12.70
8.13
6.54
17.54
24.19
31.13
40.90
53.01
110.80
110.50

Balance Sheet

Balance Sheet
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Total Assets
197
205
247
291
251
267
303
345
419
513
658
Fixed Assets
105
109
137
131
128
123
113
104
124
114
172
Current Assets
86
87
96
143
97
126
176
207
264
298
465
Capital Work in Progress
1
2
2
9
17
10
12
31
25
96
16
Investments
0
0
0
0
0
0
0
0
58
91
127
Other Assets
92
94
108
152
106
134
178
210
211
212
343
Total Liabilities
197
205
247
291
251
267
303
345
419
513
658
Current Liabilities
67
67
79
121
78
83
80
80
103
131
120
Non Current Liabilities
5
5
21
16
13
8
7
9
9
7
7
Total Equity
125
134
147
155
161
177
216
256
308
375
531
Reserve & Surplus
112
120
134
142
147
163
203
243
294
362
517
Share Capital
13
13
13
13
13
13
13
13
13
13
13

Cash Flow

Cash Flow
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
0
0
1
-1
0
0
40
17
-32
-5
9
Investing Activities
-10
-15
-30
-16
-19
-11
-8
-35
-106
-79
-42
Operating Activities
-2
33
7
15
46
50
58
65
91
94
78
Financing Activities
12
-18
23
0
-27
-39
-11
-14
-17
-20
-27

Share Holding

% Holding
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Promoter
72.07 %
72.07 %
72.07 %
72.07 %
72.07 %
72.41 %
72.61 %
72.61 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.81 %
72.95 %
72.95 %
72.95 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.46 %
0.56 %
0.89 %
1.14 %
1.35 %
1.30 %
1.45 %
1.35 %
DIIs
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
0.01 %
2.04 %
2.02 %
2.12 %
2.29 %
3.59 %
3.79 %
4.19 %
4.63 %
5.45 %
6.06 %
6.14 %
6.48 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
20.45 %
20.59 %
20.58 %
20.65 %
20.85 %
20.37 %
19.91 %
20.26 %
19.91 %
19.45 %
18.41 %
18.16 %
17.41 %
16.79 %
15.92 %
15.58 %
15.33 %
15.46 %
Others
7.47 %
7.33 %
7.34 %
7.28 %
7.07 %
7.21 %
5.44 %
5.10 %
5.16 %
5.45 %
4.73 %
4.67 %
4.70 %
4.62 %
4.47 %
4.11 %
4.12 %
3.76 %
No of Share Holders
18,701
20,564
23,674
22,768
22,821
22,115
20,757
21,360
20,837
20,226
21,088
21,866
22,137
22,232
23,481
24,891
24,867
25,832

Dividend History

Dividends per share (FY)
Dividend yield (FY) %
Dividends per share (FY)
Dividend yield (FY) %
Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 2.8 2.4 2.4 4 7.2 9.6 12 16 24
Dividend Yield (%) 0.00 0.73 0.97 1.41 1.03 1.28 1.4 0.79 0.7 1.06

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
25 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Jul 2025 2,548.80 2,515.25
16 Jul 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
16 Jul 2025 2,341.50 2,557.00
27 Jun 2025 DIVIDEND Dividend
₹ 4.00 /share
27 Jun 2025 2,244.30 2,424.10
27 Jun 2025 DIVIDEND Dividend
₹ 20.00 /share
27 Jun 2025 2,244.30 2,424.10
28 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
28 Apr 2025 2,197.25 2,244.30
24 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
24 Jan 2025 2,067.10 2,166.65
07 Nov 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
07 Nov 2024 2,443.95 2,673.90
16 Jul 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
16 Jul 2024 1,535.60 1,640.55
28 Jun 2024 DIVIDEND Dividend
₹ 16.00 /share
28 Jun 2024 1,560.55 1,599.95
21 Jul 2023 DIVIDEND Dividend
₹ 12.00 /share
21 Jul 2023 820.55 996.65
15 Jul 2022 DIVIDEND Dividend
₹ 9.60 /share
14 Jul 2022 589.35 568.55
17 Aug 2021 DIVIDEND Dividend
₹ 7.20 /share
13 Aug 2021 490.80 516.85

Announcements

Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 26, 2025
Amendment In Policy Of The CompanyJul 25, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 25, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementJul 25, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 25, 2025
Unaudited Financial Result For The Quarter Ended On June 30 2025Jul 25, 2025
Board Meeting Outcome for Outcome Of The Board Meeting Held On July 25 2025Jul 25, 2025
Board Meeting Intimation for Board Meeting Intimation To Consider And Approve Unaudited Financial Results For The Quarter Ended June 30 2025Jul 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 18, 2025
Voting Result Of 18Th Annual General MeetingJul 16, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 16, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 16, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 14, 2025
Closure of Trading WindowJun 25, 2025
Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The CompanyJun 24, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 24, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jun 23, 2025
Reg. 34 (1) Annual Report.Jun 23, 2025
Notice Of 18Th Annual General Meeting Scheduled On Wednesday July 16 2025.Jun 23, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 16, 2025
Intimation Of Record Date For 18Th AGM Of The Company Scheduled On July 16 2025. Jun 14, 2025
Email Communication To Shareholders Regarding Dividend Taxation ProvisionsJun 05, 2025
Further To Our Letter Dated April 28 2025 We Enclose Herewith Updated Annexure C Pursuant To Details Required As Per SEBI Circular No. SEBI/HO/CFD/CFD-Pod-1/P/CIR/2023/123 Dated July 132023.Jun 03, 2025
Intimation To Shareholders Holding Shares In Physical Mode Regarding Furnishing Of PAN KYC Details And NominationJun 03, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJun 02, 2025
In Accordance With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("Listing Regulations") To Shareholders Whose Shares Are Liable To Be Transferred To IEPF Authority.Jun 01, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 29, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 23, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 05, 2025
Earning Call Audio Recording Link For Q$ Ended On March 31 2025.Apr 29, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationApr 29, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationApr 29, 2025
Amendment Of PoliciesApr 28, 2025
Disclosure Under 30(5) Of SEBI (Listing Obligations And Disclosure Requirement) Regulations 2015Apr 28, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 28, 2025
Corporate Action-Board approves DividendApr 28, 2025
Appointment Of Secretarial Auditor For Term Of Five (5) YearsApr 28, 2025
Announcement under Regulation 30 (LODR)-Change in DirectorateApr 28, 2025
Financial Result For Quarter And Year Ended On March 31 2025Apr 28, 2025
Board Meeting Outcome for Audited Financial Result For Quarter And Year Ended On March 31 2025Apr 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationApr 23, 2025
Board Meeting Intimation for Pursuant To Regulation 29 Of The SEBI LODR 2015 This Is To Inform You That A Meeting Of The Board Of Directors Of The Company Is Scheduled On Monday April 28 2025Apr 21, 2025
Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure AApr 19, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 11, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementApr 08, 2025
Closure of Trading WindowMar 25, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Mar 21, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationFeb 25, 2025
Update On Transfer Of Surplus Vacant Leasehold LandFeb 13, 2025
Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Feb 07, 2025

Technical Indicators

RSI(14)
Neutral
39.95
ATR(14)
Less Volatile
87.98
STOCH(9,6)
Neutral
27.02
STOCH RSI(14)
Neutral
35.69
MACD(12,26)
Bearish
-13.90
ADX(14)
Weak Trend
16.16
UO(9)
Bearish
46.89
ROC(12)
Uptrend And Accelerating
0.12
WillR(14)
Neutral
-76.46

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Mirae Asset Multicap Fund Direct - Growth
0.85%
-20261
-0.16%
-0.13%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.00%
-16535
-1.13%
-1.09%
Bandhan BSE Healthcare Index Fund Direct-Growth
0.08%
-2
0.00%
0.01%
Motilal Oswal Quant Fund Direct-Growth
0.00%
0
0.00%
-0.54%
Quant Healthcare Fund Direct - Growth
8.83%
0
0.05%
0.96%
Quant Multi Cap Fund Direct-Growth
0.44%
0
0.01%
0.05%
Union Small Cap Fund Direct-Growth
0.79%
0
-0.03%
0.02%